Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Archives of Gynecology and Obstetrics|March 16, 2024
Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in GermanyJakob Draxler, Andreas Meisel, Frauke Stascheit, et al.
Scientific Reports|September 27, 2022
Motor unit number index (MUNIX) in the D50 disease progression model reflects disease accumulation independently of disease aggressiveness in ALSTheresa Ebersbach, Annekathrin Roediger, Robert Steinbach, et al.
Annals of Clinical and Translational Neurology|December 21, 2025
Remote Monitoring in Myasthenia Gravis: Exploring Symptom VariabilityMaike Stein, Maximilian Mönch, Meret Herdick, et al.
Journal of Autoimmunity|September 10, 2025
Calprotectin and neurofilament serum levels correlate with treatment response in myasthenia gravis under intensified therapy-A pilot studyFrauke Stascheit, Daniel Schulze, Sophie Lehnerer, et al.
Annals of Clinical and Translational Neurology|November 20, 2025
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and EculizumabLea Gerischer, Frauke Stascheit, Maximilian Mönch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 27, 2024
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World StudyFrauke Stascheit, Carla Daiane Ferreira de Sousa, Annette Aigner, et al.
European Journal of Neurology|April 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From GermanyLea Gerischer, Maike Stein, Alice Schneider, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.
Journal of Neurology|February 27, 2026
Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort studyMenekse Oeztuerk, Niklas Huntemann, Lea Gerischer, et al.
Pageof 3